Qi Zheng

Dr. Qi Zheng

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
JGJenny A. Greig
Jenny A. Greig
KMKelly M. Martins
Kelly M. Martins
CBCamilo Breton
Camilo Breton
RLR. Jason Lamontagne
R. Jason Lamontagne
YZYanqing Zhu
Yanqing Zhu
JWJames M. Wilson
James M. Wilson
The development of liver-based adeno-associated virus (AAV) gene therapies is facing concerns about limited efficiency and durability of transgene expression. We evaluated nonhuman primates following intravenous dosing of AAV8 and AAVrh10 vectors for over 2 years to better define the mechanism(s) of transduction that affect performance. High transduction of non-immunogenic transgenes was achieved, although expression declined over the first 90 days to reach a lower but stable steady state. More than 10% of hepatocytes contained single nuclear domains of vector DNA that persisted despite the loss of transgene expression. Greater reductions in vector DNA and RNA were observed with immunogenic transgenes. Genomic integration of vector sequences, including complex concatemeric structures, were detected in 1 out of 100 cells at broadly distributed loci that were not in proximity to genes associated with hepatocellular carcinoma. Our studies suggest that AAV-mediated transgene expression in primate hepatocytes occurs in two phases: high but short-lived expression from episomal genomes, followed by much lower but stable expression, likely from integrated vectors.

1 February 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
QZQi Zheng
Qi Zheng
BCBrian Capell
Brian Capell
VPVishwas Parekh
Vishwas Parekh
COConor O’dAy
Conor O’dAy
CACem Atillasoy
Cem Atillasoy
JSJohn T. Seykora
John T. Seykora

14 September 2024 in Cells
Verified
Journal Article
Open access
PDF file
ELElise Lemanski
Elise Lemanski
BCBailey Anne Collins
Bailey Anne Collins
AEAndrew T. Ebenezer
Andrew T. Ebenezer
SASudha Anilkumar
Sudha Anilkumar
VLVictoria A. Langdon
Victoria A. Langdon
EWElizabeth Wright-Jin
Elizabeth Wright-Jin
Neonatal hypoxic-ischemic encephalopathy (HIE) occurs in 1.5 per 1000 live births, leaving affected children with long-term motor and cognitive deficits. Few animal models of HIE incorporate maternal immune activation (MIA) despite the significant risk MIA poses to HIE incidence and diagnosis. Our non-invasive model of HIE pairs late gestation MIA with postnatal hypoxia. HIE pups exhibited a trend toward smaller overall brain size and delays in the ontogeny of several developmental milestones. In adulthood, HIE animals had reduced strength and gait deficits, but no difference in speed. Surprisingly, HIE animals performed better on the rotarod, an assessment of motor coordination. There was significant upregulation of inflammatory genes in microglia 24 h after hypoxia. Single-cell RNA sequencing (scRNAseq) revealed two microglia subclusters of interest following HIE. Pseudobulk analysis revealed increased microglia motility gene expression and upregulation of epigenetic machinery and neurodevelopmental genes in macrophages following HIE. No sex differences were found in any measures. These results support a two-hit noninvasive model pairing MIA and hypoxia as a model for HIE in humans. This model results in a milder phenotype compared to established HIE models; however, HIE is a clinically heterogeneous injury resulting in a variety of outcomes in humans. The pathways identified in our model of HIE may reveal novel targets for therapy for neonates with HIE.

13 January 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
ASAlina D. Schmidt
Alina D. Schmidt
CMCharlene Miciano
Charlene Miciano
QZQi Zheng
Qi Zheng
MMMary Elizabeth Mathyer
Mary Elizabeth Mathyer
EGElizabeth A. Grice
Elizabeth A. Grice
CSCristina De Guzman Strong
Cristina De Guzman Strong
Terminally differentiated keratinocytes are critical for epidermal function and are surrounded by involucrin (IVL). Increased IVL expression is associated with a near-selective sweep in European populations compared with those in Africa. This positive selection for increased IVL in the epidermis identifies human adaptation outside of Africa. The functional significance is unclear. We hypothesize that IVL modulates the environmentally sensitive vitamin D receptor (VDR) in the epidermis. We investigated VDR activity in Ivl‒/‒ and wild-type mice using vitamin D agonist (MC903) treatment and comprehensively determined the inflammatory response using single-cell RNA sequencing and associated skin microbiome changes using 16S bacterial phylotyping. VDR activity and target gene expression were reduced in Ivl‒/‒ mouse skin, with decreased MC903-mediated skin inflammation and significant reductions in CD4+ T cells, basophils, macrophages, monocytes, and type II basal keratinocytes and an increase in suprabasal keratinocytes. Coinciding with the dampened MC903-mediated inflammation, the skin microbiota of Ivl‒/‒ mice was more stable than that of the wild-type mice, which exhibited an MC903-responsive increase in Bacteroidetes and a decrease in Firmicutes. Together, our studies in Ivl‒/‒ mice identify a functional role for IVL to positively impact VDR activity and suggest an emerging IVL/VDR paradigm for adaptation in the human epidermis.

30 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ELElise Lemanski
Elise Lemanski
BCBailey Anne Collins
Bailey Anne Collins
AEAndrew T. Ebenezer
Andrew T. Ebenezer
SASudha Anilkumar
Sudha Anilkumar
VLVictoria Langdon
Victoria Langdon
EWElizabeth Wright-Jin
Elizabeth Wright-Jin
Neonatal hypoxic ischemic encephalopathy (HIE) occurs in 1.5 per 1000 live births, leaving affected children with long-term motor and cognitive deficits. Few animal models of HIE incorporate maternal immune activation (MIA) despite the significant risk MIA poses to HIE incidence and diagnosis. Our non-invasive model of HIE pairs late gestation MIA with postnatal hypoxia. HIE pups exhibited a trend toward smaller overall brain size and delays in the ontogeny of several developmental milestones. In adulthood, HIE animals had reduced strength and gait deficits, but no difference in speed. Surprisingly, HIE animals performed better on the rotarod, an assessment of motor coordination. There was significant upregulation of inflammatory genes in microglia 24 hours after hypoxia. Single cell RNAseq revealed two microglia subclusters of interest following HIE. Pseudobulk analysis revealed increased microglia motility gene expression and upregulation of epigenetic machinery and neurodevelopmental genes in macrophages following HIE. No sex differences were found in any measures. These results support a two-hit noninvasive model pairing MIA and hypoxia as a model for HIE in humans. This model results in a milder phenotype compared to established HIE models; however, HIE is a clinically heterogeneous injury resulting in a variety of outcomes in humans. The pathways identified in our model of HIE may reveal novel targets for therapy for neonates with HIE.

1 January 1995 in Journal of Parallel and Distributed Computing
Verified
Journal Article
Closed access
OIO.H. Ibarra
O.H. Ibarra
QZQi Zheng
Qi Zheng